Background-Healthcare-associated infections (HAIs) are preventable. Globally, laws aimed at reducing HAIs have been implemented. In the USA, these laws are at the federal and state levels. It is not known whether the state interventions are more effective than the federal incentives alone.
Objective-The aims of this study were to explore the impact federal and state HAI laws have on state departments of health and hospital stakeholders in the USA and to explore similarities and differences in perceptions across states.
Methods-A qualitative study was conducted. In 2012, we conducted semistructured interviews with key stakeholders from states with and without state-level laws to gain multiple perspectives. Interviews were transcribed and open coding was conducted. Data were analysed using content analysis and collected until theoretical saturation was achieved.
Results-Ninety interviews were conducted with stakeholders from 12 states (6 states with laws and 6 states without laws). We found an increase in state-level collaboration. The publicly reported data helped hospitals benchmark and focus leaders on HAI prevention. There were concerns about the publicly reported data (eg, lack of validation and timeliness). Resource needs were also identified. No major differences were expressed by interviewees from states with and without laws.
Conclusions-While we could not tease out the impact of specific interventions, increased collaboration between departments of health and their partners is occurring. Harmonisation of HAI definitions and reporting between state and federal laws would minimise reporting burden. Continued monitoring of the progress of HAI prevention is needed.
BACKGROUND
For over 15 years, public disclosure of hospital outcome data has been thought to improve patient safety. 1 One of the most serious issues for ensuring patient safety is preventing healthcare associated infections (HAIs); at any given time, an estimated 1 in 25 hospitalised patients in the USA has a HAI, leading to significant morbidity and mortality. 2 The Centers for Disease Control and Prevention (CDC) estimated the annual national hospital costs of HAI to be US$25-31 billion. 3 These data, coupled with growing demand for transparency and accountability by policy makers, have led several countries to legally mandate the public reporting of HAI indicators including England, France and the USA. 4 In the USA, HAI reporting laws have been enacted at the federal and state levels. 56 In 2008, the federal Department of Health and Human Services implemented a national Action Plan for reducing HAIs across healthcare and identifying measureable goals. 7 In support of the Action Plan, further federal initiatives were legislated. For example, as part of the American Recovery and Reinvestment Act of 2009 (Public Law 111-5, 42 U.S.C 241(a)), US$40 million were appropriated through the CDC. These funds were available to all states to support state departments of health (DOH) for HAI prevention planning and infrastructure including supporting a state-specific dedicated programme coordinator (HAI coordinator). As part of the Patient Protection and Affordable Care Act of 2010 (Public Law 111-148), the Hospital Value Based Purchasing Program built on earlier legislation that allowed Medicare to pay hospitals for reporting quality measures, rather than on the quantity of care (eg, service or patient counts). This programme included the Inpatient Quality Reporting Program requiring hospitals to report specific HAIs to the CDC's National Healthcare Safety Network to receive full Medicare payment.
The federal laws apply across all 50 states and provide incentives only; these interventions do not mandate action. As of 2013, 37 states (including the District of Columbia and Puerto Rico) have introduced laws that require facilities to report HAI indicators to each state's DOH, which then may report HAI data publicly. 8 While there is support of the general concept of HAI prevention, the evidence on the benefits of public reporting has been inconclusive and opinions are mixed. 910 Furthermore, it is not known whether the state interventions are more effective than the federal legislation alone. Therefore, our aims were to explore the impact federal and state HAI laws have on state DOH and hospital stakeholders in the USA and to explore the similarities and differences in perceptions from those in states with and without state-level laws.
STUDY DESIGN AND METHODS
Our research team conducted a qualitative public health law study. [11] [12] [13] This design was chosen because of its inductive nature, which may provide invaluable insights from multiple perspectives.
Selection of states
First, a legal review was conducted to determine the states that had HAI reporting laws. LexisNexis research system databases were used along with other relevant administrative law resources to capture state statutes and administrative regulations. To ensure accuracy, HAI coordinators in states and territories with legal reporting mandates (n=36 at the time of our study) were contacted and verification was obtained. Figure 1 displays all states with and without mandatory reporting laws as of 1 May 2012. States were purposefully sampled to include equal numbers of those with and without state-level mandatory reporting laws and to ensure geographical variety until theoretical saturation was achieved.
Selection of participants
From each of the states, stakeholders with key roles (ie, state DOH HAI personnel, regulatory or legal officials, clinicians and community partners) were purposefully recruited to elicit multiple perspectives. Using a snowballing technique, each state's HAI coordinator was asked to recommend knowledgeable individuals from each role. At least 5 and up to 10 participants were recruited from each state based on availability, willingness to participate and theoretical saturation.
Interviews
Semistructured interview guides (available upon request) were tailored to the key roles and state type (ie, state-level law or no law). These guides were based on: (1) Donabedian's quality framework that proposes evaluation of healthcare delivery should be based on the quality of system structure, process and outcomes, (2) our legal review and (3) knowledge gained from previous research. All interview guides included demographic and openended questions about the impact state and federal laws have on structure of the state HAI programme; changes in the programme; working relationships in HAI prevention; community and non-governmental partnerships; HAI data uses; funding; and lessons learned.
A two-person interview team was trained by the investigators (PWS and JAM) so there would be consistent interviewing techniques used. 17 Prior to beginning, the interview team piloted all procedures. Interviews were audiotaped, professionally transcribed and reviewed for accuracy.
Analysis
Transcripts were entered into NVivo 10 (QSR International) software and identified by state and role only. All data were combined. Transcripts were read several times by multiple team members to gain an understanding of the data. An inductive open coding process was conducted by two research assistants who were supervised by the investigators (PWS and JAM). Coding began as soon as transcripts were received and throughout the coding process, two transcripts were double coded on a bi-weekly basis and per cent agreement was computed and adequate (ie, >90%). Discrepancies were discussed until a consensus was reached. Throughout the interviewing and coding process, weekly debriefings occurred with all research team members to ensure a shared understanding of the data. Using a qualitative content analysis approach, 18 coded data were reviewed to develop themes, looking for similarities and differences between respondents from states with and without state-level laws. This comprehensive, conscious and collaborative analysis contributes to the credibility of the findings.
RESULTS
Theoretical saturation was achieved after recruiting 12 states (see figure 2) . Of the states with HAI mandatory reporting laws, Arkansas, Colorado, New York, Ohio, Tennessee and Texas were selected (randomly assigned numbers from 1 to 6). Arizona, Georgia, Kansas, Kentucky, Nebraska and Wisconsin were states selected without laws (randomly assigned numbers from 7 to 12).
Ninety interviews were conducted and the respondent roles included: (1) state DOH officials and HAI coordinators; (2) DOH regulatory officials and legal counsel; (3) clinicians involved in HAI prevention including infection preventionists (IPs), hospital epidemiologists, and department managers from acute care and specialty care settings (eg, dialysis); and (4) community partners including state hospital association representatives, quality improvement organisation representatives, and if applicable, consumer advocates. Table 1 describes the key stakeholders by state type. A majority (59%) came from states with HAI laws.
Our findings are organised around four themes: increased collaboration, using public reported data for benchmarking and prioritising, concerns related to public reported data and resource needs. Narrative exemplar quotes supporting each theme from the various stakeholders from states with and without laws are provided below. Table 2 displays the narratives consistent with the themes by role and state type. There is some dissimilarity in the narrative responses by role (ie, only 50% of regulatory or legal stakeholders discussed resource needs compared with 70-80% of the other stakeholders). The narratives are similar from stakeholders from states with and without state-level laws. This respondent also discussed the collaboration between the hospital association and the hospitals as follows:
We're very hands-on. We've become an extension of each hospital's team and use regional expertise to coach and mentor hospitals. (Participant 39, hospital association representative, state 4)
Using publicly reported data for benchmarking and prioritising
Publicly reported data were useful in obtaining the focus of the hospital administrators and gaining support for local prevention efforts. It was perceived that state and federal level HAI reporting laws influenced the prioritisation of infection prevention efforts. Due to institutional accountability and reputation, the publicly reported data helped hospitals benchmark and focus leaders on HAI prevention. This benchmarking often translated into an increased recognition of the importance of infection prevention in the facility as explained below:
When you take data…put names along with it…put it on a website or in the newspaper…you see monumental change in the interest and funding that the CEO The data resulting from the state reporting mandate were useful for prioritising state prevention efforts as described in the following: 
Concerns related to publicly reported data
There were concerns about the data reported as a result of the HAI laws. These concerns stemmed from a need for validation and standardisation of definitions as well as the specificity and timeliness of the aggregated publicly reported data to inform practice. As discussed below, inconsistently defined data for benchmarking between institutions was seen as problematic:
The worry would be whether everybody was collecting data the same way and if we were capturing really what we thought we were capturing. (Participant 46, IP, state 7)
Many stakeholders expressed doubts about using unvalidated data as described:
Data validation is also important. You know there are quite a few states that publish reports, but the data aren't validated. (Participant 27, DOH official, state 4)
The concern about validation was echoed in the following statement:
We're collecting all of this information, but we haven't validated the data, and while I trust that we have a very savvy and robust network of IPs, I think folks would feel a lot more comfortable with the data knowing that some validation has occurred. (Participant 65, DOH official, state 10)
Others were concerned about the timeliness and specificity of the data; state-specific data were perceived as timelier than federal data as described in the following: Many stakeholders expressed concern that meeting reporting requirements (ie, federal and state) overburdened the IPs leaving little time for development and execution of interventions aimed at prevention. As one respondent explained:
Many of our IPs complain that they're spending all of their time doing data entry, collection and management and have very little time for education and infection prevention efforts. When you're spending all of your time collecting all this different data, there is not enough time to actually do the infection prevention effort, so those are unintended consequences. (Participant 28, community representative, state 5)
DISCUSSION
We explored perceptions of the impact federal and state HAI laws have on state DOHs and hospital stakeholders in the USA and similarities and differences in perceptions from those working in states with and without state-level laws. While some findings were expected others were surprising.
We found there was a perception that state HAI laws fostered a climate of collaboration.
There is a growing evidence base establishing the efficacy of HAI prevention collaboratives that emphasise health system change through surveillance, data feedback, systematic implementation of prevention measures, and intrafacility and interfacility collaboration. [19] [20] [21] Other researchers have surveyed DOH about their HAI prevention activities and found that between 2009 and 2011, just prior to our study period, federal funding had resulted in 60 prevention collaboratives. 22 Therefore, it is not surprising that we found increased partnerships described by interviewees in all states. What was not known was the partnerships were frequently attributed to the role the state DOH played as a convenor and leader.
Stakeholders from both types of states (ie, with state-level laws and without) discussed how the publicly reported data were used to benchmark and prioritise HAI prevention efforts. The federal financial incentives were perceived to be an important motivator for healthcare facility prevention efforts. This is despite a lack of evidence on the efficacy of the federal incentives; in 2008, researchers found that federal non-payment policy did not affect rates of targeted HAIs. 23 However, that research only focused on the non-payment policy, which was found to have negligible impact on hospital finances. 24 The more recent value-based purchasing programme may act as a stronger financial incentive. Even without clear evidence of the efficacy of financial incentives, publicly reported data were considered useful for engaging institutional leadership around issues of harm reduction and reputation.
It is not surprising that validation of publicly reported data and use of standard definitions were seen as paramount by stakeholders. The importance of data validation has been recognised by the CDC. 25 Without validation, there may be incentives to under-report due to the data being tied to payment and hospital reputation. In Europe, due to concerns about under-reporting as well as potential to negatively impact prevention efforts, experts are in favour of reporting process indicators over HAI rates. 10 The timeliness and specificity of the data were persistent concerns among the respondents, a problem also identified in prior CDC HAI stakeholder engagement activities. 514 The benefit of rapid-cycle feedback to clinicians and hospital administration is well known 26 and given sufficient staffing, facilities would be expected to provide feedback to clinicians directly while providing their state DOH with data. Indeed, the CDC's National Healthcare Safety Network provides two mechanisms for facilities to voluntarily share HAI data with their state DOH: the National Healthcare Safety Network Group Function and data use agreements between the CDC and individual state DOHs. These resources afford states and the individual hospital immediate access to data to focus prevention efforts.
Sustainable resources and funding for HAI programmes were identified as important themes. State DOHs that are facing budget cuts depend on vulnerable programmatic funding streams and must balance competing priorities against scarce resources. 27 Targeted funding can play a critical role in reducing HAIs. 21 While increased resources for infectious disease epidemiology and laboratory capacity have recently been awarded through the CDC, future funding is not guaranteed. 28 Respondents repeatedly expressed a need for experienced personnel, especially IPs. Over the past few decades, the role of IPs has changed. 29 IPs have shifted their focus from merely monitoring infections to proactively intervening to prevent them and have expanded their scope to lead performance improvement teams. 30 However, with mandatory reporting, some IPs are forced to spend more time on surveillance and less time on preventing infections. 31 While the focus of responses varied slightly by role, we were surprised we did not uncover major differences in those from states with or without state reporting laws. We attribute this to the impact of federal HAI prevention initiatives on stakeholders in all states. It is possible that the state laws had an impact on healthcare delivery processes and may have laid the groundwork for the federal legislation. However, we cannot definitively determine that impact with our current data.
Limitations
This study has limitations; findings need to be interpreted with caution. Efforts were made to have a diverse sample of states and respondents to gain multiple perspectives. However, the respondents did not represent all states and the findings may have limited transferability. The data are narrative self-report and bias due to social desirability cannot be ruled out.
CONCLUSIONS
Legal interventions such as state-level reporting mandates and value based purchasing federal incentives should be, in theory, associated with decreasing HAIs. While we could not tease out the impact of specific interventions, progress has been made in the effort to eliminate HAIs; however, more work is needed to improve patient safety and reduce HAIs. Continued monitoring of the progress made towards goals to decrease HAIs is needed. To prevent HAIs, collaboration between public health agencies and their partners in the healthcare sector is essential. Harmonisation of HAI definitions and reporting between state and federal laws would minimise reporting burden. States participating in the study. 
